The Food and Drug Administration on Wednesday sent 20 letters to companies in the burgeoning stem cell industry, telling them they are selling an unapproved product in violation of federal laws.
It also sent a more formal letter of warning to a company that makes umbilical cord blood products that have been used by such stem cell
